Acquired Factor XI Inhibitor in Systemic Lupus Erythematosus—Case Report and Literature Review

Objectives Rare patients with systemic lupus erythematosus (SLE) patients exhibit anticoagulants that interfere in the earlier stages of the intrinsic coagulation pathway, such as those involving factor XI (FXI). The objectives of our study were to describe the presence of an acquired inhibitor to F...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Seminars in arthritis and rheumatism 2009-08, Vol.39 (1), p.61-65
Hauptverfasser:	Bortoli, Rodrigo, MD, Monticielo, Odirlei A., MD, Chakr, Rafael M., MD, Palominos, Penélope E., MD, Rohsig, Liane M., MSc, Kohem, Charles L., MD, PhD, Xavier, Ricardo M., MD, PhD, Brenol, João Carlos T., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences bleeding disorders Blood Coagulation - immunology Blood Coagulation Disorders - blood Blood Coagulation Disorders - drug therapy Blood Coagulation Disorders - immunology circulating anticoagulant coagulopathy Diseases of the osteoarticular system factor XI Factor XI - antagonists & inhibitors Factor XI - immunology factor XI inhibitor Female Hematologic and hematopoietic diseases Humans Immunosuppressive Agents - therapeutic use Lupus Erythematosus, Systemic - blood Lupus Erythematosus, Systemic - immunology Medical sciences Platelet diseases and coagulopathies Rheumatology Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis systemic lupus erythematosus Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!